Time for Treatment
Government-subsidised DAAs may not always be available
T
he clock is ticking to eliminate hepatitis C in Australia as a public health issue, and Hepatitis Australia is sounding the alarm.
in Australia if all people living with hepatitis c take ñôĆñþĄñ÷õ ÿö Ąøõ ñŀÿĂôñòüõ ñþô õŀõóĄùĆõ óąĂõ ±ôùĂõóĄ« acting antiviral therapy) that is currently available.
The goal of NOHep by 2030 is realistic and achievable
Talking to the ABC, the CEO of Hepatitis Australia, Helen
2
HEPATITIS SA COMMUNITY NEWS 77 • March 2018
Tyrell, explained that fewer than half as many people are currently accessing the direct-acting antivirals as there were immediately after Ąøõĉ ćõĂõ ŁĂ㥠üùăĄõô ÿþ Ąøõ æøñĂýñóõąĄùóñü ØõþõŁĄă éóøõýõ ±æØé² ßþ Ąøõ ŁĂ㥠three months after the listing,
